India’s HealthTech ecosystem is gaining momentum, driven by innovators working at the intersection of healthcare, engineering, and data science. Strengthening this momentum, the Technology Innovation Hub at IIT Bombay is set to host ATMAN 3.0, an eight-week accelerator programme designed to convert promising early-stage HealthTech ideas into investment-ready ventures. With seed funding support of INR 1 crore or more for each winning startup and a high-impact Demo Day scheduled for January 9, 2026, ATMAN 3.0 positions itself as a critical launchpad for the next wave of healthcare innovation.
A national platform for translational innovation
Backed by the National Mission on Interdisciplinary Cyber-Physical Systems and the Department of Science and Technology, the Technology Innovation Hub at IIT Bombay operates as a not-for-profit Section 8 company focused on translating research into real-world impact. Its work spans healthcare, BFSI, agriculture, Industry 5.0, smart infrastructure, and education. Through ATMAN 3.0, the Hub is deepening its engagement with HealthTech founders who are building solutions grounded in science, usability, and scalability.
The current ATMAN 3.0 cohort includes 13 startups selected from a competitive pool of 173 applicants. These ventures address critical gaps across medical devices, digital health, rehabilitation, diagnostics, and emergency care. Innovations range from precision needle tracking systems and robotic rehabilitation devices to AI-powered wearables, digital therapeutics, and smart monitoring solutions for seniors and patients with chronic conditions. Together, the cohort reflects the breadth of challenges and opportunities shaping India’s healthcare future.
ATMAN 3.0 is structured across eight modules covering market discovery, product development, business strategy, financial planning, regulatory readiness, and investor engagement. Startups benefit from continuous mentorship by clinicians, domain experts, and business leaders, ensuring that innovation is balanced with clinical relevance and commercial feasibility. The programme is designed to move founders beyond prototypes, helping them build solutions that can scale responsibly within complex healthcare systems.
Leadership perspective on building impact
Kiran Shesh, CEO of TIH IIT Bombay, highlighted that ATMAN 3.0 is designed to accelerate HealthTech innovators from research to real-world adoption. He emphasised the importance of structured mentorship, regulatory guidance, and investor access in helping startups address challenges across diagnostics, rehabilitation, chronic care, and emergency response. Hardik Joshi, COO of TIH IIT Bombay, added that the accelerator serves as a launchpad for founders to innovate responsibly, with patient-centric outcomes at the core of product development.
The programme will culminate in a Demo Day at Novotel, Mumbai International Airport, where startups will pitch to investors, industry leaders, and the investment committee. Beyond funding, the event will feature discussions on healthcare investment trends, regulatory frameworks, and emerging business models, along with networking opportunities for founders and stakeholders.
As India works toward its vision of Viksit Bharat 2047, ATMAN 3.0 reinforces IIT Bombay TIH’s mission of building a sustainable bridge between research and enterprise. By supporting HealthTech innovators from concept to commercialization, the accelerator is strengthening India’s position as a global hub for next-generation healthcare technologies.
